LONDON & LUXEMBOURG--(BUSINESS WIRE)--Advanced Biological Laboratories (ABL) S.A. and the HIV Resistance Response Database Initiative (RDI) are pleased to announce their collaboration to enhance HIV patient management. As the first milestone of the collaboration, data stored on ABL’s health management system, TherapyEdge®, can now be automatically uploaded to RDI’s HIV Treatment Response Prediction System (HIV-TRePS), providing the physician with predictions of how their patient will respond to any combination of HIV drugs, in a matter of seconds.
Help employers find you! Check out all the jobs and post your resume.
